Eargo | Jotup

Eargo to Present at 39th Annual J.P. Morgan Healthcare Conference

Retrieved on:

Lundi, décembre 21, 2020

Audiology, Occupational safety and health, Eargo, Hearing loss, Otorhinolaryngology, Health sciences, Medical specialties

SAN JOSE, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced it will present at the 39th Annual J.P. Morgan Healthcare Conference via web cast.

Key Points:

SAN JOSE, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced it will present at the 39th Annual J.P. Morgan Healthcare Conference via web cast.
Christian Gormsen, Eargos President and Chief Executive Officer, is scheduled to present on Tuesday, January 12th at 2:00pm Eastern Time.
Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss.
The companys 4th generation product, the Eargo Neo HiFi, was launched in January and features improved capabilities across audio fidelity and bandwidth.

Eargo to Announce Third Quarter 2020 Financial Results

Retrieved on:

Lundi, novembre 9, 2020

Audiology, Occupational safety and health, Otorhinolaryngology, Eargo, Hearing loss, NASDAQ, Health sciences, Medical specialties

SAN JOSE, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Eargo Inc., (NASDAQ: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it will release financial results for the third quarter of 2020 after market close on Thursday, November 19, 2020.

Key Points:

SAN JOSE, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Eargo Inc., (NASDAQ: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it will release financial results for the third quarter of 2020 after market close on Thursday, November 19, 2020.
On the same day, Eargo will host a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its financial results and recent highlights.
Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss.
The companys 4th generation product, the Eargo Neo HiFi, was launched in January and features improved capabilities across audio fidelity and bandwidth.

Eargo Doubles Commitment From $500,000 to $1,000,000 in Value for Healthcare Professionals and Their Families in Need of Hearing Aids

Retrieved on:

Mercredi, avril 22, 2020

Health, Otology, Otorhinolaryngology, Hearing aid, Auditory system, Occupational safety and health, Audiology, Hearing loss, Eargo, Food and Drug Administration

This offer is an expansion of the company's previous commitment of $500,000 worth of value, as announced on March 30 .

Key Points:

This offer is an expansion of the company's previous commitment of $500,000 worth of value, as announced on March 30 .
To qualify for a 20 percent discount on Eargo products, healthcare workers can call 1-800-266-6060 for a free consultation and to purchase hearing aids for themselves or their families.
We believe our Eargo hearing aids are the first and only virtually invisible, rechargeable, completely-in-canal, FDA regulated, exempt Class I device for the treatment of hearing loss.
Our differentiated, consumer-first solution empowers consumers to take control of their hearing with personalized, high-quality hearing support from licensed hearing professionals; all packaged with Eargo devices at less than half the cost of competing hearing aids.

Eargo Wins Gold Edison Award in Hearing Technology Design with Eargo Max

Retrieved on:

Jeudi, avril 11, 2019

Audiology, Hearing, Perception, Articles, Otology, Hearing aid, Eargo, Edison Awards

SAN JOSE, Calif., April 11, 2019 /PRNewswire-PRWeb/ --Eargo, the health tech company that's destigmatizing hearing loss through consumer-driven innovation, was awarded a Gold Edison Award in the hearing technology design category for the Eargo Max.

Key Points:

SAN JOSE, Calif., April 11, 2019 /PRNewswire-PRWeb/ --Eargo, the health tech company that's destigmatizing hearing loss through consumer-driven innovation, was awarded a Gold Edison Award in the hearing technology design category for the Eargo Max.
"We are honored and thankful to the judging committee to be awarded Gold in Hearing Technology at the Edison Awards" said Christian Gormsen, CEO of Eargo.
Eargo is best known for the Eargo Max, a rechargeable hearing aid that fits discreetly inside the customer's ear, removing the social stigmas traditionally associated with hearing aids.
To learn more about Eargo, and to order a set of their award-winning Eargo Max hearing aids, please visit https://shop.eargo.com/ .

Eargo named Best Companies for Perks & Benefits in Comparably Q3 Awards

Retrieved on:

Jeudi, octobre 4, 2018

Otology, Occupational safety and health, Medicine, Audiology, Hearing aid, Employee benefits, Hearing loss, Eargo, Health, Otorhinolaryngology

MOUNTAIN VIEW, Calif., Oct. 4, 2018 /PRNewswire-PRWeb/ -- Eargo , the health tech company that's destigmatizing hearing loss through consumer-driven innovation, was awarded Best Companies for Perks & Benefits for this quarter's Comparably Award .

Key Points:

MOUNTAIN VIEW, Calif., Oct. 4, 2018 /PRNewswire-PRWeb/ -- Eargo , the health tech company that's destigmatizing hearing loss through consumer-driven innovation, was awarded Best Companies for Perks & Benefits for this quarter's Comparably Award .
"This set of Comparably Awards focuses on companies that most reward their employees," said Jason Nazar, CEO of Comparably.
"These employers stand out as the best of the best providing amazing benefits and great work-life balance to foster some of the happiest employees in the United States."
Eargo is best known for the Eargo Max , a rechargeable hearing aid that fits discreetly inside the user's ear, removing the social stigmas traditionally associated with hearing aids.